Oyster Point Pharma, Inc.

NJ · United States · Reporting entity ID 100001156899

Total reported 2019–2025

$20.9M

#309 of 2,960 reporting companies — 0% of all reported industry payments

$5.83M in general payments across 82,386 records, plus $15.1M in research funding across 1,290 records.

How it breaks down

General payments $5,833,682

Research funding $15,098,353

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.